NIH Foundation, Biomarkers Consortium Team on Cancer Trials

The I-SPY effort will conduct pharmacogenomics-focused clinical trials for breast cancer drugs using Agendia's tests.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories